At the very heart of our Biblical tradition is this commandment from the Book of Leviticus: You shall not stand idly by the blood of your fellow. (Leviticus 19:16)
If we see our sisters or brothers in danger, our job is simple: Provide that help, come to their aid, do what is in our power to protect them and save them.
In the midst of a global pandemic, we feel the call to protect and promote the health and well-being of others even more urgently. Right now, we hear the call to uphold the ultimate Jewish value of pikuach nefesh (saving a life).
Sometimes, we live out that value in an immediate way. We donate blood today, which can save lives in real time. We provide support for basic needs to ensure that people in our community have enough to eat right now. But if we truly wish to move the needle in the work of pikuach nefesh, we must also provide resources to fund research over many years, even decades, that will, ultimately, yield dramatic results.
To truly make a difference, to be Gods partners in bringing healing to the world, we must not stand idly by in both immediate and long-term ways.
California voters have an opportunity to do just this by voting yes on Proposition 14, which will advance the California Institute of Regenerative Medicines stem cell research to help those who are affected by ailments including heart disease, diabetes, Alzheimers, Parkinsons disease, sickle cell disease, spinal cord injuries, Covid-19, and so many other chronic illnesses and injuries.
Funding for this important and vital medical research helps save lives, and it will provide immediate economic stimulus, as well. Even as it funds long-term strategies to alleviate human suffering, Prop. 14 will create jobs during this challenging time. Recent studiessuggest that Prop. 14 would generate approximately $20 billion in increased economic activity in California, yielding more than 100,000 new jobs at every level. This far surpasses Prop. 14s estimated cost of $5.5 billion in bonds.
Critics of the proposition question the need for such funding on a state level today. They argue that Proposition 71, the initiative that originally created the California Institute of Regenerative Medicine, was passed in 2004 only because President George W. Bush had banned federal funding for stem cell research. Now that federal funding for stem cell research is allowed, the critics charge, its no longer Californias responsibility to fund such research; private and federal funding should be used to continue this important work.
However, relying on federal and private funds is too risky. Many in our country wish to stifle and limit stem cell research on religious grounds. Far more importantly, Jewish law on this matter is unequivocal: stem cell research is not just permitted, but, arguably, required as a matter of pikuach nefesh. Numerous halachic authorities have made this clear. It should, therefore, come as no surprise that some of the most exciting work in stem cell research is currently being done in Israel.
Medical experts agree that stem cell research and therapies will save lives and alleviate human suffering. In fact, it already has. One example is the stem cell work Dr. Donald Kohn at UCLA conducted to cure ADA-SCID bubble baby disease.
This work is too important for us to leave it to chance or to allow it to be cut off or limited.
We see Prop. 14s opportunity to provide such resources for life-saving research as a blessing, the fulfillment of core Jewish values.
Just one chapter before the commandment to not stand idly by, our Torah reminds us that the purpose of mitzvot, the very goal of Judaism, is to enhance life. We are commanded: in the pursuit of My laws and statutes you shall live. (Leviticus 18:5) The Rabbis of the Talmud interpret this verse to mean that the ultimate value, above all else, is life itself.
To be sure, it will take many years to realize the promise of current research. But like the well-known story of Honi, who came upon an old man planting a tree that would not bear fruit for another 70 years, we recognize that our efforts are not for ourselves alone. Just as our ancestors sacrificed so that our lives would be better, we commit ourselves to doing the same for our descendants.
The voices of our sisters and brothers cry out to us: friends and family members with diabetes; co-workers fighting against cancer; loved ones slipping away due to the cruel ravages of Alzheimers.
They call out to us in their pain. They are searching for hope.
We cannot stand idly by. We must generously sacrifice so that they and subsequent generations might live and be well.
There are quite literally lives to be saved. Join us by voting yes on Prop, 14 on Nov. 3.
Go here to see the original:
- Cellino is using AI and machine learning to scale production of stem cell therapies - TechCrunch - September 22nd, 2021
- Capping Medicare Part B payments will limit outpatient access to CAR-T - STAT - September 22nd, 2021
- Treating Patients with High-Risk Myelodysplastic Syndrome - Targeted Oncology - September 22nd, 2021
- FDA Issues Draft Guidance on Donor Eligibility and Manufacturing of Cellular Therapies for Animals | FDA - FDA.gov - September 22nd, 2021
- CD19 As a Targeted Agent in CAR T Cell Therapy for R/R DLBCL - Targeted Oncology - September 22nd, 2021
- Stem Rx Bioscience Solutions successfully use cell-based therapy for age-related macular degeneration and restoration of vision - Financial Express - September 22nd, 2021
- Repeated injury to the epithelial tissue of airways causes "biological aging" of stem cells - News-Medical.net - September 22nd, 2021
- Revival of the cell and gene therapy field opens new avenues for repairing the Parkinsonian brain - News-Medical.Net - September 22nd, 2021
- Scientists Awarded The Albany Prize, America's Most Distinguished Prize in Medicine, for Research Leading to Covid-19 Vaccines - Albany Medical Center - September 22nd, 2021
- Why I Believe It Is Wrong To Take The COVID Vaccine - And Response - The Chattanoogan - September 22nd, 2021
- How can fertility counseling be implemented for every newly diagnosed pediatric patient facing gonadotoxic ... - Physician's Weekly - September 20th, 2021
- Mantle Cell Lymphoma Treatment in the Era of COVID-19 - Curetoday.com - September 20th, 2021
- Calloway County Health Department announces 23 new cases of COVID-19 - Murray Ledger and Times - September 20th, 2021
- Effects of Leukemia on Your Body - Healthline - September 20th, 2021
- DCGI approves stem cell-based therapy trial for COVID-19 pneumonia treatment - BSI bureau - September 17th, 2021
- Dr. Anderson on the Challenges Faced With CAR T-Cell Therapy in Myeloma - OncLive - September 17th, 2021
- Treatment Methods: Transplant Eligibility in R/R DLBCL and CAR T Cell Therapy - Targeted Oncology - September 17th, 2021
- Insights into the cellular and molecular changes in male infertility - EurekAlert - September 17th, 2021
- Loss of Vision Caused by AMD: Cell-Based Therapy Can Help Restore Your Eyesight - TheHealthSite - September 17th, 2021
- The Promise of Regenerative Medicine to Treat Chronic Pain - Newswise - September 17th, 2021
- Researchers build the ovarian environment using mouse stem cells - News-Medical.net - September 17th, 2021
- Molecular and Cellular Changes in the Testicular Tissue of Infertile Men Revealed - Technology Networks - September 17th, 2021
- Magenta Therapeutics Announces IND Clearance for MGTA-117 Targeted Conditioning Clinical Trial - Yahoo Finance - September 17th, 2021
- Indolent lymphoma: Symptoms, outlook, treatment, and more - Medical News Today - September 17th, 2021
- Dr. Shah on Unmet Needs With CAR T-Cell Therapy in Multiple Myeloma - OncLive - September 17th, 2021
- Researchers focus on improving biomaterials used for bone and tissue repair - News-Medical.net - September 17th, 2021
- Dr. Kahl on Patient Selection for Intensive Vs Non-Intensive Treatment in MCL - OncLive - September 17th, 2021
- Orchard Therapeutics Outlines Differentiated Profile of Its HSC Gene Therapy Approach and ... - The Bakersfield Californian - September 14th, 2021
- Meet the Finnish team using stem cells to cure blindness - Sifted - September 14th, 2021
- Why you should feel optimistic about the future of healthcare - Say - Say Communications - September 14th, 2021
- Treating Hearing Loss: The Hunt for Drugs That Promote Hair Cell Regeneration - Technology Networks - September 14th, 2021
- Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and... - September 14th, 2021
- Celebrating the End of Cancer Treatment - Curetoday.com - September 14th, 2021
- BlueCross Will Cover Costs for COVID-19 Booster - Business Wire - September 14th, 2021
- UAB opening vaccination sites in Hoover and Ensley - UAB News - September 12th, 2021
- CardiAMP Cell Therapy Heart Failure Trial to be Featured in Two Presentations at Heart Failure Society of America Annual Meeting 2021 - Yahoo Finance - September 10th, 2021
- A Knee or Hip Replacement Without Surgery? Its on the Horizon - The Wall Street Journal - September 10th, 2021
- Jerry Nelson: Stem cell treatment can be alternative to joint replacement - Watertown Public Opinion - September 10th, 2021
- Graft Vs Host Prophylaxis With Posttransplant Cyclophosphamide Not Associated With Increased Infection Risk - Hematology Advisor - September 10th, 2021
- Carolina Researchers Lead CZI Collaborative on Childhood Diseases | Newsroom - UNC Health and UNC School of Medicine - September 10th, 2021
- A New Opportunity To Receive Sight - mvprogress - September 8th, 2021
- Japan: A case study of national readiness for regenerative medicine - Open Access Government - September 8th, 2021
- Merger Proposals Blocked By Cell Therapies Developer - Labmate Online - September 8th, 2021
- Using Predictive, Data Analytics to Expand Knowledge of Alzheimer's - HealthITAnalytics.com - September 8th, 2021
- Research on preterm brain injury treatment recognised - Medicine, Nursing and Health Sciences - Monash University - September 8th, 2021
- Roche bets $300M on Adaptimmune tech for off-the-shelf cell therapies for cancer - MedCity News - September 8th, 2021
- Desperate family have just three weeks to find stem cell donor for their girl - Express - September 8th, 2021
- Ivy Tech nursing student among 234 who want religious exemption to vaccine mandate - The Indianapolis Star - September 8th, 2021
- Convection Improves Survival and Insulin Secretion of Beta Cell Implants - Genetic Engineering & Biotechnology News - September 8th, 2021
- Bone Therapeutics reports half year 2021 results - GlobeNewswire - September 8th, 2021
- How a Family's Persistence Led to Their Son's Successful Sickle Cell TreatmentWith the Help of My Special Aflac Duck EBONY - EBONY - September 8th, 2021
- Leukemia Awareness Month: Changing the Future of AML through Precision Medicine - Targeted Oncology - September 8th, 2021
- Third Line Therapies in R/R FL - Cancer Network - September 8th, 2021
- BMS opts-in on Evotec's neurodegenerative medicine - PharmaTimes - September 7th, 2021
- New Cancer Treatments May Be on The Horizon Thanks to Success in mRNA Vaccine Trial - Good News Network - September 7th, 2021
- Billionaires Have Reportedly Invested In A BioTech Company Aiming To Reverse Aging - IFLScience - September 7th, 2021
- Human Mini-Lungs Grown in Lab Dishes are Closest Yet to Real Thing - UC San Diego Health - September 1st, 2021
- Targeting and inhibiting a protein could provide more effective treatment for brain cancer - News-Medical.Net - September 1st, 2021
- Could gene therapies be used to cure more people with HIV? - aidsmap - September 1st, 2021
- BioRestorative Therapies Receives Patent in Japan Related to its Off-the-Shelf ThermoStem Program - Yahoo Finance - September 1st, 2021
- Future Therapeutic Options for Diffuse Large B-Cell Lymphoma - Targeted Oncology - September 1st, 2021
- COVID-19 Causes Severe Disease, Disrupted Treatment in Children with Cancer - Pharmacy Times - September 1st, 2021
- Blood cancer and its impact on female fertility - Lexology - September 1st, 2021
- New gene therapies may soon treat dozens of rare diseases, but million-dollar price tags will put them out of reach for many - The Conversation US - September 1st, 2021
- Global Cryopreservation Equipment Market Report 2021-2028 - Growing Acceptance for Regenerative Medicine & Increasing Needs of Biobanking... - August 30th, 2021
- Bengaluru boy with rare disease meets his German stem cell donor - The Hans India - August 30th, 2021
- Novartis falls behind rivals in race to bring CAR-T to early lymphoma - BioPharma Dive - August 30th, 2021
- Mike Tysons weird stem cell treatment has helped transform incredible body at 55 - Daily Star - August 28th, 2021
- University of Miami Researchers Enter Phase 3 of Stem Cell Clinical Trial in Treating COVID-19 Acute Respiratory Distress Syndrome - Newswise - August 28th, 2021
- Incyte and MorphoSys Announce the European Commission Approval of Minjuvi (tafasitamab) in Combination With Lenalidomide for the Treatment of Adults... - August 28th, 2021
- College of Medicine University of Central Florida Research Wounds Heal Faster with New Treatment: Military Medicine Discovery - PRNewswire - August 28th, 2021
- Lab-grown minibrains with eyes may advance personalized drug testing, researchers say - Mahoning Matters - August 28th, 2021
- Off-the-Shelf NK Cell Products FT596 and FT516 Show Early Promise in B-cell Lymphoma - OncLive - August 28th, 2021
- BioMarin stands tall with first approved drug for rare disease that causes dwarfism - MedCity News - August 28th, 2021
- What to know about the third COVID-19 shot in Gainesville, Alachua County - Gainesville Sun - August 28th, 2021
- Department of Public Health Offering Third Dose COVID-19 Vaccines to Eligible Individuals | Monroe County, NY - monroecounty.gov - August 28th, 2021
- Cell Culture Protein Surface Coating Market | Know the Diverse Growth Parameters Influencing the Market - BioSpace - August 23rd, 2021
- County providing COVID-19 third dose booster to immunocompromised - City of Fort Worth - August 23rd, 2021
- Outcomes For MCL Patients and Impact of Relapse Timing After Transplant on OS - Targeted Oncology - August 23rd, 2021
- SGMC Offering COVID-19 Third Dose to Immunocompromised People - sgmc.org - August 23rd, 2021